Overview

Gender

male

Mr. Vromen has served as the Vice President of Business Development at Koor Chemicals, a Director on the Board of Tambour Ltd., Agan Chemicals Ltd., as well as the Joint Managing Director of Plantex and Ikapharm (Koor's pharmaceutical ventures). Mr. Vromen has also acted as a management consultant to Teva Pharmaceutical Industries Ltd. and BioTechnology General Ltd., two of Israel's leading pharmaceutical and biotechnology companies.

Since 1993, Mr. Vromen has acted as the General Manager of SBRC Ltd., which is the Management Company of the Astra Fund ($10 M) and since 1996 he is an active member of the Board of Directors of the First IsraTech Fund. The Astra Portfolio Companies include medical equipment, biotechnology, communications and agricultural firms. The First IsraTech Fund ($14 M) has invested in Israeli and Israeli related high technology companies, in the medical and industrial fields.

Mr. Vromen holds a B.Sc. degree in Chemical Engineering from Imperial College (London, UK) as well as a business diploma from the Hebrew University of Jerusalem.